Experimental Immune Reset Therapy Brings Lupus Into Remission in Early UK Trials
An innovative treatment using genetically modified immune cells has put lupus into remission for patients in early UK trials. The approach offers hope for lasting relief from this chronic autoimmune disease and may extend to other conditions like multiple sclerosis and rheumatoid arthritis.